Document is current
Any future updates will be listed below
-
Authors
Zhou, Mengping https://orcid.org/0000-0002-6117-0690
Larsson, Henrik https://orcid.org/0000-0002-6851-3297
D’Onofrio, Brian M.
Landén, Mikael
Lichtenstein, Paul https://orcid.org/0000-0003-3037-5287
Pettersson, Erik
-
Funding
Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2023-00402)
Svenska Läkaresällskapet (SLS-943288)
Stiftelsen Söderström Königska Sjukhemmet (SLS-968742)
- License Information
-
More Information
Article History
Received: 12 September 2024
Revised: 4 March 2025
Accepted: 21 March 2025
First Online: 1 April 2025
Competing interests
: HL reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; all outside the submitted work. HL is editor-in-chief of JCPP Advances. ML has received lecture honoraria from Lundbeck pharmaceuticals. All other authors have declared that they have no competing or potential conflicts of interest.
: This study was conducted in accordance with the Declaration of Helsinki and complies with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. This study was approved by the Swedish Ethical Review Authority (Dnr 2013/862-31/5). Informed consent was not required because this study used de-identified registry data.
